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Abstract
Background: Cancer risks of migrants might differ from risks of the indigenous population due to
differences in socioeconomic status, life style, or genetic factors. The aim of this study was to
investigate cancer patterns among children of Turkish descent in Germany.
Methods: We identified cases with Turkish names (as a proxy of Turkish descent) among the
37,259 cases of childhood cancer registered in the German Childhood Cancer Registry (GCCR)
during 1980–2005. As it is not possible to obtain reference population data for children of Turkish
descent, the distribution of cancer diagnoses was compared between cases of Turkish descent and
all remaining (mainly German) cases in the registry, using proportional cancer incidence ratios
(PCIRs).
Results: The overall distribution of cancer diagnoses was similar in the two groups. The PCIRs in
three diagnosis groups were increased for cases of Turkish descent: acute non-lymphocytic
leukaemia (PCIR 1.23; CI (95%) 1.02–1.47), Hodgkin's disease (1.34; 1.13–1.59) and Non-Hodgkin/
Burkitt lymphoma (1.19; 1.02–1.39). Age, sex, and period of diagnosis showed no influence on the
distribution of diagnoses.
Conclusion: No major differences were found in cancer patterns among cases of Turkish descent
compared to all other cases in the GCCR. Slightly higher proportions of systemic malignant
diseases indicate that analytical studies involving migrants may help investigating the causes of such
cancers.
Background
The population of migrants in Germany comprises more
than 7 million people with a Non-German nationality,
and about 8 million national Germans with a migrant
background. Thus, about 15 million or 19% of the resi-
dent German population have a migration background.
This figure includes former guest workers, who came to
Germany in the 70ies and 80ies mostly from south east
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Europe, refugees from all over the world and naturalised
or ethnic German migrants from the former Soviet Union
[1]. The number of migrant children is increasing. About
1 million children aged 0–15 years currently have a Non-
German citizenship. The largest group of children with a
Non-German citizenship in Germany are migrants from
Turkey, comprising about 25% [2]. On the other hand,
the number of naturalised children of Turkish origin with
German nationality is increasing.
So far knowledge about the cancer risk of children with a
migrant background in Germany is scarce. However, the
available evidence indicates that the question is worth
studying. There is evidence of world wide geographic var-
iation in the incidence of childhood cancer [3]. In the
Globocan 2002 database [4], the incidence rates of chil-
dren in Turkey and Germany show differences: in Turkey,
children aged 0–14 years have a higher incidence of
Hodgkin's disease and non-Hodgkin lymphoma and a
lower incidence of leukaemia and brain tumours com-
pared to German children. It is unclear whether this differ-
ence is due to methodological differences (different data
quality, different ways of data collection, different com-
pleteness and representativeness) or is indeed an expres-
sion of real differences in incidence. In Sweden,
Hemminki & Li found increased cancer risks for migrant
children of different origins and for different diagnoses
compared to Swedish children, e.g. for lymphoma among
children with Turkish parents [5].
In Germany, most routine health data do not contain
valid and complete information on migrant status. Infor-
mation on citizenship is unhelpful because it excludes the
large and increasing number of migrants with German
nationality. For example, the GCCR routinely collects no
information relevant to migration status of registered
cases. The underlying reasons are practical – the notifying
physician or pathologist is often not aware of the migrant
status of the diagnosed patient – rather than ethical. There
is no legal requirement concerning in – or exclusion of
indices of migrant status in a case report to the cancer reg-
istry. In consequence, migrant-specific analyses of cancer
patterns or cancer risk are not available. This study, for the
first time, presents data about childhood cancer for chil-
dren with Turkish names in Germany.
Methods
In Germany, all cases of childhood cancer are registered in
a central register, the German Childhood Cancer Registry
(GCCR) in Mainz. Between 1980–2005, 37,259 cancer
cases below 15 years of age have been registered with open
names based on parental consent. The completeness of
registration and the quality of data are high and comply
with international standards. More than 95% of all child-
hood cancer cases are registered; only for brain tumours
the proportion is slightly lower [6]. This high complete-
ness was reached in 1987 for the area of the former Fed-
eral Republic of Germany and shortly after the German
reunification in 1990 for the area of the former German
Democratic Republic. While the GCCR data has been used
for a number of epidemiologic analyses, so far no investi-
gations stratified for migration background or ethnicity
have been possible. As previously explained, In the GCCR
no data about citizenship, ethnic background or place of
birth have routinely been collected in the past. Therefore,
little is known about the cancer risk of migrant children in
general and of children of Turkish origin in Germany in
particular.
We applied a recently developed name-based approach to
identify children of Turkish origin in the data base of the
GCCR, which has been successfully used in previous stud-
ies [7,8]. The name algorithm is based on the high specif-
icity of Turkish names as compared to German, central
European, Arabic, or Asian names. This high specificity is
the result of a name reform in Turkey in the 1930s when
all inhabitants of Turkey had to adopt family names with
a meaning in the Turkish language. Consequently, a per-
son with a Turkish name has a very high probability of
being of Turkish descent.
The name algorithm uses a list of more than 13,000
known Turkish family and first names to identify Turkish
persons in the data base. It has an automatic part and a
manual part. In the first automatic part, persons with
names, which are definitely Turkish, were identified. Per-
sons with names that are possibly Turkish or so called
"doublets", i.e. rare names common in the German and
Turkish language, were assessed in a second manual step
by a native Turkish person, using all other available infor-
mation (names of the parents, place of birth etc.) as far as
available from patient records. To examine the perform-
ance of the name algorithm, all cases were checked again
manually by a Turkish expert to create a 'gold standard'. A
more detailed description of the methodology and per-
formance of the name algorithm is published elsewhere
[9].
We classified the cancer cases into 12 diagnosis groups
(Table 1). Classification was adapted from the Interna-
tional Classification of Childhood Cancer [10]. We then
calculated proportional cancer incidence ratios (PCIR) for
these diagnosis groups and compared the relative inci-
dence of individual cancers among Turkish and non-Turk-
ish (for the most part German) children. PCIRs compare
the proportion of one diagnosis site or group, in relation
to all cancer cases. Thus, if 10% of all Turkish cases had
brain tumours compared to 5% of all Non-Turkish cases,
the PCIR would be 10% divided by 5%, resulting in aBMC Public Health 2008, 8:152 http://www.biomedcentral.com/1471-2458/8/152
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PCIR of 2. For PCIRs, confidence intervals can be calcu-
lated using established methods [11].
In the analyses we stratified for age, sex, and year of diag-
nosis. This was necessary because the number of cases as
well as the proportion of Turkish cases differed between
1980 and 2005 due to changes in the completeness of reg-
istration and the German reunification in 1990. To test for
confounding or interactions we performed a multiple
logistic regression using proportional incidence odds
ratios with one diagnostic group as 'event' and the other
diagnostic groups as 'control' including descent (Turkish
versus Non-Turkish), age (in age groups), sex, and time
period of diagnosis (in years) as independent variables.
Incidence (or risk) ratios, like the PCIR, are in general
more conservative than odds ratios due to the larger
denominator in incidence ratios. Therefore we calculated
the proportional cancer incidence odds ratios in a regres-
sion model only to check for confounding or interaction
between the independent variables. Here we only show
the crude and stratified PCIRs.
We considered different ways to conduct not only propor-
tional analyses but to estimate actual incidence rates. For
this purpose we evaluated different approaches to esti-
mate the population under risk for the Turkish cases.
However, only population data on children with Turkish
nationality in Germany are available, which exclude the
naturalised children of Turkish descent. We decided not
use these data as this would have led to a substantial over-
estimation of the true cancer risk of the Turkish cases due
to an underestimation of the population at risk.
Results
The name algorithm performed well with a high sensitiv-
ity and specifity, and we identified 1774 childhood cancer
cases of Turkish descent (Figure 1).
The proportion of cases with Turkish names is not
dependent on sex or age group; this is true for all cancers
as well as specific cancer diagnoses and years of diagnosis.
The male-female ratio is 1.42 for cases with Turkish names
and 1.27 for the comparison cases.
The PCIRs were close to one for most diagnostic groups.
They were significantly above one for acute non-lym-
phocytic leukemia, Hodgkin's disease and Non-Hodgkin/
Burkitt Lymphoma (Table 2). The observation of higher
PCIRs for these three diagnostic groups was consistent,
but not always statistically significant after stratification
for sex (Table 3 &4), and age groups (see Additional file
1). The proportion of retinoblastoma was slightly lower
among Turkish cases than among non-Turkish cases after
stratification for age; nephroblastoma were significantly
less frequent among Turkish children in the age group 5–
<10 years (see Additional file 1). The PCIRs did not
change in the regression model accounting for sex, age
group and year of diagnosis (results of regression model
not shown) and no confounding or effect modifications
between the independent variables were found. Therefore
we present the unadjusted PCIRs.
Discussion
Our study provides insight into the distribution of cancer
among Turkish migrant children in Germany. This group
Table 1: Classification of cancer cases into 12 diagnosis groups and corresponding ICD-O-2 codes
Diagnostic group ICD-O-2 codes
Lymphoid leukaemia 9820–9827, 9850
Acute non-lymphocytic leukemia 9840, 9481, 9861, 9864, 9866, 9867, 9891, 9894, 9910
Hodgkin's disease 9650–9667
Non-Hodgkin/Burkitt Lymphoma 9591–9595, 9670–9686, 9690–9714, 9723, 9687
CNS tumors 9383, 9390–9394, 9380, 9381, 9400–9441, 9470–9473, 9380, 9382, 9384, 9442–9460, 9481, 8270–
8281, 8300, 9350–9362, 9480, 9505, 9530–9539, 8000–8004
Neuroblastoma and ganglioneuroblastoma 9490, 9500
Retinoblastoma 9510–9512
Nephroblastoma 8960, 8963, 8964,
Malignant bone tumours 9180–9200, 9220–9230, 9231–9240, 9260, 9363, 9364, 8812, 9250, 9261–9330, 9370, 8000–8004, 
8800, 8801, 8803, 8804
Soft-tissue sarcomas 8900–8920, 8991, 8810, 8811, 8813–8833, 9540–9561, 9140, 8840–8896, 8982, 8990, 9040–9044, 
9120–9134, 9150–9170, 9251, 9581, 8963, 9231, 9240, 9363, 9364, 9260, 8800–8804
Germ-cell tumors 9060–9102, 8010–8041, 8050–8075, 8082, 8120–8122, 8130–8141, 8143, 8155, 8190–8201, 8210, 
8211, 8221–8241, 8244–8246, 8260–8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480–8490, 8504, 
8510, 8550, 8560–8573, 8380, 8381, 8441–8473, 8590–8670, 9000, 8000–8004
Other All other diagnoses including unspecified cancer sitesBMC Public Health 2008, 8:152 http://www.biomedcentral.com/1471-2458/8/152
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of Turkish migrant children defined by their Turkish
names stands for a group that has in common a descent
from Turkey. Most of these children are the offspring of
Turkish migrants who came to Germany after the 1960ies
and hence are 2nd generation migrants. The aim of this
study was to compare the cancer patterns of this group to
the patterns of the indigenous German population. The
Turkish names used as indicator here allow drawing con-
clusions only about the common descent from a country
(not the same ethnic group) as well as a common migra-
tion experience in the 1st or 2nd generation. This opera-
tionalisation of migrant status by descent from a country
is commonly used in migrant research. It is, of course, a
surrogate for a multidimensional set of factors including
genetic, behavioural and contextual variables. The indi-
vidual measurement of these factors was not possible in
our retrospective, registry-based study.
The cancer diagnoses in our study are generally similarly
distributed among Turkish and non-Turkish children and
there is no evidence that the proportion of Turkish cases
differs by age or sex group. For acute non-lymphocytic
leukemia, Hodgkin's disease and Non-Hodgkin/Burkitt
lymphoma, the proportions are slightly increased for
Turkish children. This might be the result of a truly differ-
ent cancer risk of Turkish children, for which possible
Result of the name based identification of children with Turkish names in the data base of the German Childhood Cancer Reg- istry (GCCR), 1980–2005 Figure 1
Result of the name based identification of children with Turkish names in the data base of the German Child-
hood Cancer Registry (GCCR), 1980–2005.
37259 cases in the (GCCR)
862 cases with names that 
were possibly Turkish or 
“doublets”  
35302 cases with 
names not identified 
as Turkish 
1095 cases with names 
that were definitely
Turkish
1095 cases automatically 
identified as Turkish 
 44 additional Turkish 
cases identified after 
manual revision 
1774 (4.8%) out of 37,259 cases identified as Turkish 
635 cases manually 
identified as Turkish 
Name-algorithm  Additional manual revision“
Table 2: Proportional cancer incidence ratios (PCIR) and 95% confidence intervals (95% CI) of children with Turkish names versus 
children with non-Turkish names in the German Childhood Cancer Registry 1980–2005, both sexes
Diagnosis group Turkish cases (n) Non-Turkish cases (n) PCIR (95% CI)
Lymphoid leukaemia 504 10177 0.99 (0.92–1.07)
Acute non-lymphocytic leukemia 112 1827 1.23 (1.02–1.47)
Hodgkin's disease 119 1778 1.34 (1.13–1.59)
Non-Hodgkin/Burkitt Lymphoma 152 2553 1.19 (1.02–1.39)
CNS tumors 318 6681 0.95 (0.86–1.05)
Neuroblastoma and ganglioneuroblastoma 144 2875 1.00 (0.86–1.17)
Retinoblastoma 28 804 0.70 (0.48–1.01)
Nephroblastoma 92 2167 0.85 (0.70–1.04)
Malignant bone tumours 78 1749 0.89 (0.72–1.11)
Soft-tissue sarcomas 102 2290 0.89 (0.74–1.08)
Germ-cell tumors 48 1142 0.84 (0.64–1.11)
Other 77 1442 1.07 (0.86–1.33)
Total 1774 35485 -BMC Public Health 2008, 8:152 http://www.biomedcentral.com/1471-2458/8/152
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causes or causal pathways are not yet known, or due to
chance. The confidence intervals presented here are not
adjusted for the testing of several subgroups. As we used
12 subgroups, about one spuriously significant result is
likely.
Our study has several other limitations. We performed an
explorative 'case only' analysis. The PCIR for one diagno-
sis group is by definition dependent on the PCIRs in the
other diagnosis groups as all proportions jointly always
have to sum up to 1. The PCIR is therefore not a measure
of relative risk and is somewhat difficult to interpret. An
increased PCIR for one cancer site could be the expression
of lower case frequencies for other cancer sites. Even if the
PCIR for one cancer site is increased, the overall cancer
risk can still be much lower than in the comparison group.
Misclassification due to inaccurate classification of chil-
dren with binational parents could also be a cause of bias.
Binational marriages between Turkish and German per-
sons have been scarce in the past but are becoming more
frequent over the last years. Currently there are about
79,000 Turkish-German marriages in Germany, represent-
ing about 10% of all marriages of Turkish persons.
Our findings are internally consistent. The increased
PCIRs remained elevated after stratification for sex and
age; no confounding by or interactions between these
independent variables was found.
As a first step, epidemiologic studies on cancer among
migrants such as ours frequently use a descriptive compar-
ative approach and analyse the differences of cancer pat-
terns between migrants and an indigenous/reference
population. However, most studies on cancer among
migrants focus on adult cancer [12-16], and few studies
on childhood cancer are available.
Table 3: Proportional cancer incidence ratios (PCIR) and 95% confidence intervals (95% CI) of children with Turkish names versus 
children with non-Turkish names in the German Childhood Cancer Registry 1980–2005, female children
Diagnosis group Turkish cases (n) Non-Turkish cases (n) PCIR (95% CI)
Lymphoid leukaemia 211 4430 1.02 (0.91–1.14)
Acute non-lymphocytic leukemia 49 870 1.21 (0.92–1.58)
Hodgkin's disease 41 708 1.24 (0.92–1.67)
Non-Hodgkin/Burkitt Lymphoma 44 736 1.28 (0.96–1.70)
CNS tumors 138 2944 1.00 (0.86–1.17)
Neuroblastoma and ganglioneuroblastoma 60 1327 0.97 (0.76–1.23)
Retinoblastoma 14 388 0.77 (0.46–1.30)
Nephroblastoma 42 1119 0.80 (0.60–1.08)
Malignant bone tumours 38 837 0.97 (0.71–1.32)
Soft-tissue sarcomas 36 1032 0.75 (0.54–1.03)
Germ-cell tumors 25 626 0.85 (0.58–1.26)
Other 34 646 1.13 (0.81–1.57)
Total 732 15663 -
Table 4: Proportional cancer incidence ratios (PCIR) and 95% confidence intervals (95% CI) of children with Turkish names versus 
children with non-Turkish names in the German Childhood Cancer Registry 1980–2005, male children
Diagnosis group Turkish cases (n) Non-Turkish cases (n) PCIR (95% CI)
Lymphoid leukaemia 293 5747 0.97 (0.88–1.07)
Acute non-lymphocytic leukemia 63 957 1.25 (0.99–1.59)
Hodgkin's disease 78 1070 1.39 (1.12–1.72)
Non-Hodgkin/Burkitt Lymphoma 108 1817 1.13 (0.95–1.35)
CNS tumors 180 3737 0.92 (0.80–1.05)
Neuroblastoma and ganglioneuroblastoma 84 1548 1.03 (0.84–1.27)
Retinoblastoma 14 416 0.64 (0.38–1.08)
Nephroblastoma 50 1048 0.91 (0.69–1.19)
Malignant bone tumours 40 912 0.83 (0.62–1.13)
Soft-tissue sarcomas 66 1258 1.00 (0.79–1.26)
Germ-cell tumors 23 516 0.85 (0.57–1.27)
Other 43 796 1.03 (0.77–1.38)
Total 1042 19822 -BMC Public Health 2008, 8:152 http://www.biomedcentral.com/1471-2458/8/152
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In terms of aetiogical explanations for possible risk differ-
ences, migrant children might, besides their possibly dif-
ferent genetic background or different life style, be
exposed to different patterns of infections. Concerning
acute lymphoid leukaemia, an influence of infectious
exposures caused by unusual population mixing, e.g. in
heterogeneous and transient populations, is being dis-
cussed [17,18]. On the other hand it has been suggested
that reduced exposure to infections in very young children
may be a risk factor for acute lymphoid leukaemia [19]
possibly involving lack of stimulation of the immune sys-
tem. Migrant children might be a population under partic-
ular risk for this cancer due to population mixing or
increased contact to infectious agents.
Our study of cancer patterns, however, does not lend sup-
port to the hypothesis that migrant children of Turkish
descent might have increased risks for acute lymphoid
leukemia due to differing patterns of exposure to infec-
tious agents. However, more detailed information is nec-
essary for an in-depth assessment of this issue.
The increased PCIRs for lymphomas in our study are con-
sistent with the findings of studies in migrant populations
in other countries. Hemminki et al. found an increased
risk for non-Hodgkin lymphoma for children of Turkish
parents, especially for those less than 5 years of age [16].
Cummins et al. found an increased risk for lymphoma for
South-Asian children in England [20]. The other elevated
risks demonstrated in the study by Cummins et al., espe-
cially for leukemia, are not in line with our findings.
Because of the small number of Turkish cases for some
cancer diagnoses and the resulting limited explanatory
power of the respective PCIRs, we grouped the cancer
cases in 12 diagnosis groups, including a group 'others'. A
detailed analysis of the cancer diagnoses in this latter
group showed an increased PCIR for cancer of the
nasopharynx among Turkish migrants (PCIR = 2.4, KI =
1.0–5.8, data not shown). This estimate is based on only
five Turkish cases and could be a chance finding. How-
ever, the result is consistent with the SIR of 8.2 for cancer
of the nasopharynx that Visser and Leeuwen found among
Turkish migrants in the Netherlands [21]. The increased
SIR for cancer of the liver among Turkish migrants (SIR =
4.6) in their study is not supported by our findings, but
again the number of Turkish cases with liver cancer in our
study is small.
Our data on lymphoma and nasopharyngeal cancer could
tentatively be interpreted as supportive of a higher pro-
portion of cancers associated with the Epstein-Barr virus
in children with a Turkish name. Indeed, data on child-
hood cancer from the Izmir registry in Turkey computed
through the ACCIS system [22] indicate that EBV-related
cancers may be more frequent in Turkey than in Germany.
For the period 1993–96, Burkitt lymphoma incidence in
Izmir was 4.4 per million children aged 0–14 (World
Standard), against 1.1 per million in Germany. However,
case numbers are very small and thus need to be inter-
preted with care. Nevertheless, this may be a point for fur-
ther in-depth studies.
We were restricted to the 'case only' PCIR analysis, because
of the difficulty to define the reference (denominator)
population for the children of Turkish descent. The esti-
mation of incidence rates was thus not possible in this
study. A valid reference population for the Turkish cases
would have been all children of Turkish descent living in
Germany in the years 1980–2005. However, such a popu-
lation estimate is not available. Population registries rou-
tinely collect information only on nationality but not on
descent. Thus, naturalised children of Turkish descent are
no longer identifiable. An earlier effort in the framework
of this study to estimate the number of children of Turkish
descent in the 'population under risk' using the name
algorithm in a representative sample of the population of
Germany was not successful due to major changes in the
naturalisation law in the study period (1980–2005) and
large geographical variances in the proportion of Turkish
migrants. In addition, population figures from the past
are available only in very few regions of Germany. The
large and changing differences between the proportion of
Turkish children defined by their names and defined by
nationality would introduce a considerable and uncon-
trollable numerator-denominator bias in estimating inci-
dence rates.
The name-based approach once more proved to be a use-
ful way to identify persons with Turkish descent in Ger-
many. The name algorithm performed well and had high
positive and negative predictive values [9]. The approach
has some limitations: it can only be used to identify per-
sons of Turkish descent, not migrants of other background
and it does not differentiate between the migrant genera-
tions. Stratification by country of birth was not possible
because in the database of the GCCR, the respective infor-
mation is incomplete and not validated. Thus a compari-
son of different immigrant generations (born in Turkey vs.
born in Germany) was not possible.
Conclusion
In the future, harmonized and standardized definitions in
European countries, clearly defining who is classified as a
migrant and who is not, would be very helpful. A harmo-
nized definition of migrant populations based on a stand-
ardized set of variables (1st, 2nd Generation, country of
birth, ethnicity etc.) would enable a comparable collec-
tion of migrant data in health-related and general popula-
tion data bases and thus allow for linking data fromPublish with BioMed Central    and   every 
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different data sources. Thus further research on migrant
health would be facilitated. In the case of childhood can-
cer, further research should focus on factors influencing
the cancer incidence of Turkish children and other
migrant or ethnic minority groups, and investigate etio-
logical hypotheses for specific cancers (such as haemato-
logical or EBV-related cancers).
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